Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY: SYK )

285.47 +4.76 (+1.70%)
Official Closing Price Updated: 7:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,881,350
Open 282.62
Bid (Size) 212.30 (1)
Ask (Size) 295.00 (1)
Prev. Close 280.71
Today's Range 280.93 - 285.68
52wk Range 188.84 - 285.68
Shares Outstanding 377,096,272
Dividend Yield 0.88%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stryker to announce financial results for its first quarter of fiscal year 2023
From Stryker Corporation
Via Globe NewsWire
Stryker Now Offers the Only FDA-Cleared Pyrocarbon Bearing Material Option for Shoulder Hemiarthroplasty
From Stryker
Via Business Wire

Performance

YTD
+16.03%
+16.03%
1 Month
+9.81%
+9.81%
3 Month
+16.76%
+16.76%
6 Month
+40.94%
+40.94%
1 Year
+6.78%
+6.78%

More News

Read More
The Latest Analyst Ratings for Stryker
Via Benzinga
Stryker announces Annual Meeting of Shareholders
From Stryker Corporation
Via Globe NewsWire
Should Investors Buy This Dividend Growth Stock?
Via The Motley Fool
Stryker Expects Good Momentum In 2023 Despite Some Volatility
Via Benzinga
Here's How Much $1000 Invested In Stryker 20 Years Ago Would Be Worth Today
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
Via Benzinga
3 Dividend Champions for Long-Term Income
Via InvestorPlace
Portfolio Highlights: Quarterly Movers & Shakers, March 2023
Via Talk Markets
Stryker's Earnings: A Preview
Via Benzinga
Texas Rep. Michael C. Burgess Sold Up to $500K Worth of Stryker Stock
Via Benzinga
Stryker's Debt Overview
Via Benzinga
Are These Medical Device Makers Getting Ready To Rally?
Via MarketBeat
BAX: A “Hospital Stock” To Avoid
Via Talk Markets
Interview With David Rolfe of Wedgewood Partners
Via The Motley Fool
Stryker's Q Guidance System Scores FDA Clearance For Cranial Applications
Via Benzinga
Stryker’s Q Guidance System for cranial applications receives FDA clearance
From Stryker
Via Business Wire
Stryker declares a $0.75 per share quarterly dividend
From Stryker Corporation
Via Globe NewsWire
General Motors, Bank of America And 2 Other Stocks Insiders Are Selling
Via Benzinga
Price Reversals From Recent Highs In Stocks
Via Talk Markets
Silicon Laboratories, Credit Acceptance, Stryker And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Stryker reports 2022 operating results and 2023 outlook
From Stryker Corporation
Via Globe NewsWire
Stryker, DaVita And These 2 ETFs: CNBC's 'Final Trades'
Via Benzinga
Earnings Scheduled For January 31, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.